Study of PD-1Ab21-BCMA CAR-T Therapy for Consolidation of Multiple Myelomawith Renal Dysfunction
Clinical trial NCT07489534 · RECRUITING
Trial details
- NCT number
- NCT07489534
- Sponsor
- Daihong Liu
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-29
- Primary completion
- 2027-07-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.